Tandem Diabetes Care (TNDM) Share-based Compensation Growth (1y) (2014 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Share-based Compensation Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | 18.31% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 314.20% |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 45.35% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | -78.13% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | -15.28% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 12.53% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | 10.53% |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | -13.91% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 7.56% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn | -38.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.61% |
| Mar 31, 2026 | -38.56% |
| Dec 31, 2025 | -28.60% |
| Sep 30, 2025 | -19.56% |
| Jun 30, 2025 | 2.99% |
| Mar 31, 2025 | 15.65% |
| Dec 31, 2024 | 23.86% |
| Sep 30, 2024 | 26.71% |
| Jun 30, 2024 | 6.40% |
| Mar 31, 2024 | 3.99% |
| Dec 31, 2023 | 652.27% |
| Sep 30, 2023 | 4,360.43% |
| Jun 30, 2023 | 670.50% |
| Mar 31, 2023 | -80.28% |
| Dec 31, 2022 | -82.32% |
| Sep 30, 2022 | -97.04% |
| Jun 30, 2022 | -76.34% |
| Mar 31, 2022 | 612.39% |
| Dec 31, 2021 | 28.49% |
| Sep 30, 2021 | 22.53% |